23.72
Schlusskurs vom Vortag:
$23.56
Offen:
$23.41
24-Stunden-Volumen:
306.69K
Relative Volume:
0.52
Marktkapitalisierung:
$1.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.38%
1M Leistung:
+32.96%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
Omada Health Inc Stock (OMDA) Company Profile
Firmenname
Omada Health Inc
Sektor
Branche
Telefon
888-987-8337
Adresse
500 SANSOME STREET, SAN FRANCISCO
Vergleichen Sie OMDA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OMDA
Omada Health Inc
|
23.72 | 1.37B | 0 | 0 | 0 | 0.00 |
![]()
VEEV
Veeva Systems Inc
|
270.06 | 44.25B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
78.12 | 13.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
68.52 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
97.70 | 7.68B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.23 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-01 | Eingeleitet | Barclays | Overweight |
2025-07-01 | Eingeleitet | Canaccord Genuity | Buy |
2025-07-01 | Eingeleitet | Evercore ISI | Outperform |
2025-07-01 | Eingeleitet | Goldman | Buy |
2025-07-01 | Eingeleitet | JP Morgan | Overweight |
2025-07-01 | Eingeleitet | Morgan Stanley | Overweight |
2025-07-01 | Eingeleitet | Needham | Buy |
Alle ansehen
Omada Health Inc Aktie (OMDA) Neueste Nachrichten
Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest
Omada Health announce research on cost savings of virtual physical therapy - TipRanks
Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest
Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest
$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan
Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance
Virtual Healthcare Leader Omada Health to Present at Morgan Stanley's 23rd Global Healthcare Conference - Stock Titan
Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest
Omada Health stock rises on market debut - MSN
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health price target raised to $28 from $27 at Canaccord - TipRanks
Omada Health price target raised to $24 from $21 at Barclays - TipRanks
Omada Health Reports Strong Q2 2025 Growth - TipRanks
Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks
Omada Health beats on revenue in first earnings report since IPO - CNBC
Omada Health Reports Second Quarter 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health Sets Q2 Earnings Date: Virtual Healthcare Leader Reports August 7 - Stock Titan
Interleukin Inhibitors Market Generated Opportunities, Future Scope by 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Omada Health, Inc.: A Promising Buy Amid Technical Weakness and Growth Potential - TipRanks
IPO market remains 'sluggish' despite recent San Francisco listings - The Business Journals
EQBK issues 1.73M shares, completes NBC merger & adds new director | OMDA SEC FilingForm 4 - Stock Titan
More than $16B in med-tech funding raised through 1H25 - BioWorld MedTech
The Making of Omada Health | Omada Health Co-Founder & CEO Sean Duffy - iHeart
These are the 9 healthcare startups next in line to go public, according to bankers and investors - Business Insider
Omada Health IPO signals healthier market, avoids ‘down-round’ trend - MSN
Health Coach Market Set to Witness Significant Growth by 2025-2032 | Noom, Inc., HealthifyMe, Omada Health - newstrail.com
Omada Health Stock (OMDA): A Growth Story in Digital Health - Value The Markets
Omada Health stock initiated with Buy rating at Freedom Broker - Investing.com
Finanzdaten der Omada Health Inc-Aktie (OMDA)
Es liegen keine Finanzdaten für Omada Health Inc (OMDA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):